Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Closing Bell 22 November

Grady Wulff
November 22, 2022

Morning Bell 22 November

Sophia Mavridis
November 22, 2022

Closing Bell 21 November

Grady Wulff
November 21, 2022

Morning Bell 21 November

Grady Wulff
November 21, 2022

Weekly Wrap 18 November

Bell Direct
November 18, 2022

Morning Bell 18 November

Sophia Mavridis
November 18, 2022

Closing Bell 17 November

Sophia Mavridis
November 17, 2022

Morning Bell 17 November

Grady Wulff
November 17, 2022

Closing Bell 16 November

Grady Wulff
November 16, 2022

Morning Bell 16 November

Grady Wulff
November 16, 2022

Closing Bell 15 November

Grady Wulff
November 15, 2022

Morning Bell 15 November

Sophia Mavridis
November 15, 2022